Cytology-based Cancer Surgery of the Head and Neck (CyCaS-HN): a prospective, randomized, controlled clinical trial.
Jan Philipp KühnSandrina KörnerSilke WemmertHugo RimbachJohanna HelfrichBarbara LinxweilerZoltan Ferenc TakacsErich Franz SolomayerMathias WagnerLuc G T MorrisBernhard SchickJan Philipp KühnPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2022)
Cytology-based cancer surgery is a promising therapeutic strategy that can potentially be considered for a well-defined group of early-stage HNSCC patients and help to avoid repetitive general anesthesia, shorten the diagnosis-to-treatment interval and spare operation as well as hospitalization time.
Keyphrases
- early stage
- papillary thyroid
- minimally invasive
- end stage renal disease
- coronary artery bypass
- squamous cell
- high grade
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- surgical site infection
- prognostic factors
- high frequency
- patient reported outcomes
- childhood cancer
- atrial fibrillation
- patient reported